MAPT and Alzheimer disease: To date, many of the therapeutic drugs that are used to treat AD and that target Aβ, neuroinflammation, oxidative stress, mitochondrial dysfunction, and hyperphosphorylated tau are largely unsuccessful at restoring memory.